Anticancer Drugs Oncology Pharmacology Physiotherapy Ramucirumab

Ramucirumab (30)

In this article we will discuss Ramucirumab (30)

In this article, we will discuss Ramucirumab (30). So, let’s get started.

Renal Impairment
No dose adjustment is recommended for patients with renal impairment based on population PK analysis.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.